Skip to content

Peripheral blood biomarkers in the diagnostic and prognostic of mechanical thrombectomy for patients with acute large vessel occlusion stroke (LVOS)

Peripheral blood biomarkers and their diagnostic and prognostic in patients with acute large vessel occlusion stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044853
Enrollment
Unknown
Registered
2021-03-30
Start date
2018-05-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute large vessel occlusion stroke

Interventions

Case series:Mechanical thrombectomy

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Aged more than 18 years; 2. Clinical diagnosis of ischaemic stroke; the symptoms of stroke last for more than 30 min and has not significantly relieved before treatment; 3. Modified Rankin Score less than 2 before this stroke; 4. Onset to puncture time less than 12 hours for anterior circulation stroke and less than 24 hours for posterior circulation stroke; 5. CTA, MRA or DSA was performed when clinical symptoms severity suggested proximal vessel occlusion, including internal carotid artery, middle cerebral artery (MCA)M1/M2 segment, basilar artery occlusions or dominant vertebral artery occlusions.

Exclusion criteria

Exclusion criteria: 1. Acute Stroke Prognosis Early CT score (ASPECTS) 0-6 by baseline non-contrast CT or diffusion-weighted image (DWI) in the territory of symptomatic intracranial occlusion or DWI lesion volume >70 mL for anterior circulation, or posterior circulation (pc-ASPECTS) 0-6, or Pons-midbrain index for posterior circulation; 2. Seizure at the beginning of stroke; 3. Prior stroke within the last 3 months; 4. Pre-existing neurological or psychiatric disease; 5. With less than 3 months life expectancy; 6. Previous clinical history of disease of intracranial hemorrhage, subarachnoid hemorrhage (SAH), arteriovenous malformation AVM) or tumor; 7. Increased bleeding risk disease during the last 90 days; 8. In the past 10 days with the history of hemorrhagic disease, significant trauma, or major surgery; 9. Uncompensated hypertension (systolic blood pressure more than 185 mm Hg or diastolic blood pressure more than 110 mm Hg), renal failure; 10. Platelet count less than 50x103, blood glucose less than 2.8 or more than 22.2 mmol/L; 11. Coagulation factor deficiency or under oral anticoagulant therapy with International Normalization Ratio (INR) >3.0; 12. Contraindications of digital subtraction angiography (DSA) examination; 13. Pregnant.

Design outcomes

Primary

MeasureTime frame
Functional Outcome;Degree of vascular recanalization;Intracranial Hemorrhages;Symptomatic Intracranial Hemorrhages;Routine blood indexes;Biochemical indexes;CRP;IL-6;IL-1 beta;Myoglobin, MRP8/14, NGAL, MMP-2, OPN, MPO, SAA, IGFBP-4, ICAM-1, VCAM-1, MMP-9, Cystatin C, IFN-alpha, IFN-gama, TNF-alpha, MCP-1, IL-8, IL-10, IL-12 p70, IL-17A, IL-18, IL-23, IL-33.;Other serum markers;

Secondary

MeasureTime frame
Recurrent stroke (including ICH, sICH, ischemic stroke);Other vascular events (including Myocardial infarction, pulmonary embolism, Deep venous thrombosis, etc.;The volume of the ischemic lesion;Aspect Score;NIHSS;Clot Burden;Death of any cause;

Countries

China

Contacts

Public ContactDapeng Mo

Beijing Tiantan Hospital, Capital Medical University

modapeng1971@163.com+86 18811039300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026